Related Experiment Video
Updated: Jun 13, 2026

07:14
Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
Published on: May 16, 2025
Baculovirus as a gene delivery vector for cartilage and bone tissue engineering
Chin-Yu Lin1, Chia-Hsin Lu, Wen-Yi Luo
1Department of Chemical Engineering, National Tsing Hua University, Hsinchu 300, Taiwan.
Current Gene Therapy
|April 30, 2010
Summary
Baculovirus vectors efficiently deliver genes to cartilage and bone cells. This stimulates tissue repair by promoting cell differentiation and extracellular matrix production for regenerative medicine.
Area of Science:
- Biotechnology and Genetic Engineering
- Regenerative Medicine
- Tissue Engineering
Background:
- Baculovirus is a versatile vector for gene delivery into mammalian cells.
- Chondrocytes and mesenchymal stem cells are key targets for tissue regeneration.
- Gene delivery can modulate cell behavior and stimulate tissue formation.
Purpose of the Study:
- To review the applications of baculovirus-mediated gene delivery in cartilage and bone tissue engineering.
- To discuss recent advancements and future potential of this technology.
- To identify challenges and hurdles in the field.
Main Methods:
- Review of existing literature on baculovirus gene delivery in bone and cartilage.
- Analysis of studies demonstrating growth factor expression via recombinant baculovirus.
- Evaluation of in vivo and in vitro results for tissue repair.
Main Results:
- Recombinant baculovirus effectively delivers genes to chondrocytes and mesenchymal stem cells.
- Gene expression modulates cell differentiation and extracellular matrix production.
- Baculovirus-mediated gene delivery shows promise for in vivo cartilage and bone repair.
Conclusions:
- Baculovirus is a potent tool for gene delivery in cartilage and bone tissue engineering.
- This approach facilitates cell modulation and stimulates tissue regeneration.
- Further research is needed to overcome potential hurdles for clinical translation.
